Neuromuscular Blockade in Adult Respiratory Distress Syndrome.
Acute lung injury
Adult respiratory distress syndrome
Invasive mechanical ventilation
Lung protective ventilation: paralysis
Mechanical ventilation
Neuromuscular blockade
Patent ventilator asynchrony
Journal
Clinics in chest medicine
ISSN: 1557-8216
Titre abrégé: Clin Chest Med
Pays: United States
ID NLM: 7907612
Informations de publication
Date de publication:
Dec 2024
Dec 2024
Historique:
medline:
24
10
2024
pubmed:
24
10
2024
entrez:
23
10
2024
Statut:
ppublish
Résumé
Although current clinical practice guidelines have discordant conclusions, a judicious approach to using NMBA infusions may include reserving their use for patients with early severe ARDS who are already deeply sedated and for patients under light sedation who have significant ventilator dyssynchrony, despite attempts to adjust both ventilator settings and sedation requirements. Based on current evidence, the duration of NMBA use should be limited to 48 hours, whenever possible.
Identifiants
pubmed: 39443004
pii: S0272-5231(24)00070-4
doi: 10.1016/j.ccm.2024.08.008
pii:
doi:
Substances chimiques
Neuromuscular Blocking Agents
0
Atracurium
2GQ1IRY63P
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
877-884Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Drs K.E.A. Burns and S.N. Myatra have no financial or nonfinancial conflicts of interest to disclose.